Final NICE no for Shire’s pancreatic cancer drug
admin 28th March 2017 Uncategorised 0Pancreatic cancer patients will not be able to get routine access to Shire’s Onivyde on the National Health Service following a final rejection from cost regulators
More: Final NICE no for Shire’s pancreatic cancer drug
Source: News